Bloicin-S

Bloicin-S Warnings

bleomycin

Manufacturer:

Korea United Pharma

Distributor:

Qualimed
Full Prescribing Info
Warnings
It should be used with extreme caution in patients with significant impairment of renal function or compromised pulmonary function. Pulmonary toxicities occur in 10% of treated patients. In approximately 1%, the nonspecific pneumonitis induced by Bleomycin sulfate progresses to pulmonary fibrosis, and death.
A severe idiosyncratic reaction consisting of hypotension, mental confusion, fever, chills, and wheezing has been reported in approximately 1% of lymphoma patients treated with Bleomycin sulfate. Since these reactions usually occur after the first or second dose, careful monitoring is essential after these doses.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in